Grossman Adam S — SEC insider filings
SEC reporting owner CIK 1542517. 50 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 50 filings on record, filed 2020-08-12 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 9 legs across 4 filings — 389,965 shares, $462,919 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 35 legs across 19 filings — 1,955,684 shares, $22,960,753 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 99.
- Largest priced transaction: sale of 389,356 shares @ $17.29 ($6,732,900) in ADMA BIOLOGICS, INC., filed 2024-08-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | President and CEO, Director | 50 | 9 legs · 389,965 sh · $462,919 | 35 legs · 1,955,684 sh · $22,960,753 | 99 |
Insider filings — Grossman Adam S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $13.72 · Sale (S): 6,000 @ $13.72 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-11-05 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 105,000 @ $5.40 · Sale (S): 105,000 @ $12 · Sale (S): 42,000 @ $12 · Option exercise (M): 105,000 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $15.16 · Sale (S): 6,000 @ $15.16 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 56,438 @ $15.39 · Tax withholding (F): 29,513 @ $15.39 | EDGAR |
| 2026-03-02 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 54,858 @ $15.18 | EDGAR |
| 2026-02-23 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 24,793 @ $16.32 | EDGAR |
| 2026-02-17 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $16.08 · Sale (S): 6,000 @ $16.08 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 282,529 @ $0 · Grant/award (A): 444,711 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $19.79 · Sale (S): 6,000 @ $19.79 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $16 · Sale (S): 6,000 @ $16 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-10-24 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $16 · Sale (S): 6,000 @ $16 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $16.13 · Sale (S): 6,000 @ $16.13 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $16.88 · Sale (S): 6,000 @ $16.88 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-07-16 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $18.66 · Sale (S): 6,000 @ $18.66 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $20.81 · Sale (S): 6,000 @ $20.81 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $19.45 · Sale (S): 6,000 @ $19.45 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $21.46 · Sale (S): 6,000 @ $21.46 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 15,000 @ $5.40 · Sale (S): 15,000 @ $18.92 · Sale (S): 6,000 @ $18.92 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 56,438 @ $16.91 · Tax withholding (F): 29,513 @ $17.02 | EDGAR |
| 2025-02-27 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 18,018 @ $15.44 · Tax withholding (F): 54,867 @ $15.78 | EDGAR |
| 2025-02-21 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 252,022 @ $0 · Grant/award (A): 376,744 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 14,343 @ $17.15 | EDGAR |
| 2024-11-22 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Sale (S): 48,967 @ $21.10 | EDGAR |
| 2024-10-02 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 21,752 @ $19.99 | EDGAR |
| 2024-08-27 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 64,405 @ $3.35 · Option exercise (M): 55,000 @ $5 · Option exercise (M): 16,984 @ $5.96 · Option exercise (M): 40,500 @ $9.37 · Option exercise (M): 60,000 @ $10.80 · Sale (S): 236,889 @ $17.69 · +10 more | EDGAR |
| 2024-07-02 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 21,752 @ $11.18 | EDGAR |
| 2024-06-14 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Other (J): 460,000 @ $3.21 · Gift (G): 10,000 @ $0 · Sale (S): 100,000 @ $10.72 | EDGAR |
| 2024-04-02 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 21,752 @ $6.60 | EDGAR |
| 2024-03-08 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 55,003 @ $6.12 · Tax withholding (F): 28,763 @ $6.16 | EDGAR |
| 2024-03-04 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 9,588 @ $5.36 | EDGAR |
| 2024-02-28 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 557,728 @ $0 · Grant/award (A): 870,950 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 22,457 @ $5.26 | EDGAR |
| 2024-01-05 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 23,057 @ $4.52 | EDGAR |
| 2023-10-03 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 18,718 @ $3.58 | EDGAR |
| 2023-08-18 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Sale (S): 250,000 @ $4.15 | EDGAR |
| 2023-08-17 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 212,500 @ $1.67 · Option exercise (M): 277,131 @ $2.35 · Option exercise (M): 277,604 @ $2.92 · Option exercise (M): 400,000 @ $3.22 · Option exercise (M): 350,000 @ $3.71 · Option exercise (M): 583,224 @ $3.66 · +9 more | EDGAR |
| 2023-07-05 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 20,051 @ $3.69 | EDGAR |
| 2023-04-04 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 17,853 @ $3.31 | EDGAR |
| 2023-03-08 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 4,018 @ $3.42 · Tax withholding (F): 14,412 @ $3.42 · Tax withholding (F): 7,507 @ $3.55 · Grant/award (A): 573,695 @ $0 · Tax withholding (F): 23,607 @ $3.40 · Grant/award (A): 1,147,385 (derivative) @ $0 | EDGAR |
| 2023-01-06 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 166,867 @ $3.87 | EDGAR |
| 2022-12-09 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Purchase (P): 14,983 @ $2.86 · Purchase (P): 14,982 @ $2.86 | EDGAR |
| 2022-10-04 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 101,315 @ $2.43 | EDGAR |
| 2022-05-13 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 70,004 @ $1.43 | EDGAR |
| 2022-03-25 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Tax withholding (F): 50,539 @ $1.46 | EDGAR |
| 2022-03-09 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 300,000 @ $0 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2021-10-26 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Purchase (P): 100,000 @ $1 · Purchase (P): 250,000 @ $1 | EDGAR |
| 2021-10-01 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 907,500 @ $0 · Grant/award (A): 742,500 @ $0 | EDGAR |
| 2021-03-01 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 221,447 @ $0 · Grant/award (A): 458,700 (derivative) @ $0 | EDGAR |
| 2020-09-10 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Purchase (P): 4,000 @ $2.24 | EDGAR |
| 2020-08-12 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Purchase (P): 10 @ $3.06 · Purchase (P): 2,990 @ $3.07 · Purchase (P): 2,000 @ $3.04 · Purchase (P): 1,000 @ $2.97 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1542517 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs